22840-2600 : Neurospora Intermedia 40000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution


NDC: 22840-2600
Labeler: Greer Laboratories, Inc.
Product Type: Non-standardized Allergenic
Drug Name: Neurospora Intermedia
Dosage Form: Intradermal; Percutaneous; Subcutaneous Solution
Application #: BLA101833
Rev. Date: 


NDC Package Codes:

  • 22840-2600-2: 10 ML IN 1 VIAL, MULTI‑DOSE (22840‑2600‑2)
  • 22840-2600-4: 50 ML IN 1 VIAL, MULTI‑DOSE (22840‑2600‑4)

Active Ingredients:

  • Neurospora Intermedia

Dosage Strength:

  • 40000 [PNU]/mL

Pharmaceutical Classes:

  • Allergens [CS]
  • Cell-mediated Immunity [PE]
  • Fungal Proteins [CS]
  • Increased Histamine Release [PE]
  • Increased IgG Production [PE]
  • Non-Standardized Fungal Allergenic Extract [EPC]

Related Products:

Based on records with the same trade name.
  • 22840-1699 Neurospora Intermedia .1 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-2601 Neurospora Intermedia 20000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-2602 Neurospora Intermedia .001 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-5627 Neurospora Intermedia .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 0268-0916 Neurospora Intermedia 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0917 Neurospora Intermedia 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0918 Neurospora Intermedia .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0919 Neurospora Intermedia 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0920 Neurospora Intermedia 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-6538 Neurospora Intermedia .1 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-6539 Neurospora Intermedia 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
  • 36987-2010 Neurospora Intermedia 10000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2011 Neurospora Intermedia 10000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2012 Neurospora Intermedia 20000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2013 Neurospora Intermedia 20000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2014 Neurospora Intermedia 40000 [pnu]/Ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2015 Neurospora Intermedia .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2016 Neurospora Intermedia .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2017 Neurospora Intermedia .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-2018 Neurospora Intermedia .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 22840-2600 QR Code

< Prev: 22840-2499Next: 22840-2601 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.